September 30, 2014 8:30 AM ET

Capital Markets

Company Overview of Sanofi-Genzyme BioVentures

Company Overview

Sanofi-Genzyme BioVentures is a venture capital arm of Genzyme Corp. specializing in investments in growth capital. It only invests in early-stage life science companies. The firm prefers to invest in private biotech and healthcare companies; including rare diseases, oncology, vaccines, integrated health solutions and therapies. It prefers to invest globally with a focus on North America and Europe. The firm typically invests less than or equal to $5 million in a single round of financing and a maximum of $10 million in a single portfolio company for an equity ownership of less than 20 percent. It prefers to have an advisory committee membership, board observer or director positions or SAB m...

Genzyme Center

500 Kendall Street

Cambridge, MA 02142

United States

Founded in 2001

Phone:

617-252-7500

Fax:

617-252-7600

Key Executives for Sanofi-Genzyme BioVentures

Vice President and Managing Director
Director
Senior Director of Investments
Director of Investments
Compensation as of Fiscal Year 2014.

Sanofi-Genzyme BioVentures Key Developments

Sanofi-Genzyme BioVentures Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 09:00 AM

Sanofi-Genzyme BioVentures Presents at 2013 Therapeutic Area Partnerships Conference, Nov-19-2013 09:00 AM. Venue: One Avenue De Lafayette, Boston, MA 02111, United States. Speakers: Bernard Davitian, Vice President of BD Licensing & Structured Investments and Managing Director.

Sanofi-Genzyme BioVentures Presents at Boston Biotech Conference, Apr-03-2013 11:30 AM

Sanofi-Genzyme BioVentures Presents at Boston Biotech Conference, Apr-03-2013 11:30 AM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Eric Olson, Director.

Genzyme Ventures Presents at BBC CEO New York Conference 2013, Feb-13-2013 through Feb-14-2013

Genzyme Ventures Presents at BBC CEO New York Conference 2013, Feb-13-2013 through Feb-14-2013. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States. Presentation Date & Speakers: Feb-14-2013, Alan Walts, Managing Director.

Similar Private Companies By Industry

Company Name Region
The Huntington Investment Company United States
Perseus Realty Capital, LLC United States
CP Energy Group, LLC United States
Cornerstone Financial Advisors, LLC United States
Babcock & Brown LP United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 30, 2014
Lysosomal Therapeutics Inc.
Private Placement
October 16, 2013
Immune Design Corp.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sanofi-Genzyme BioVentures, please visit www.genzyme.com/corp/licensing/genzyme_ventures.asp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.